PBMs Must Prepare For Revival Of Drug Price Transparency Requirements

 
• By Jill Drachenberg
  
Net drug price disclosure "is going to happen," said Chris O'Dell of Turquoise Health. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from PBMs

More from Market Access